Cloverdale Capital Management’s MiMedx Group MDXG Stock Holding History

Cloverdale Capital Management’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-185,000	Closed	-$1.29M	–	28
2018 Q1	$1.29M	Buy	+185,000	New	+$2.15M	0.72%	22

Other funds holding MDXG

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

TIM

Thompson Investment Management Madison, Wisconsin $872M AUM 35.59% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

WMC

Westwood Management Corporation Chicago, Illinois $270M AUM 54.59% 1-Year Est. Return

PAM

Pegasus Asset Management Montebello, New York $313M AUM 24.74% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Cloverdale Capital Management's MDXG Position: Q4 2018 in Review

Cloverdale Capital Management sold out of MiMedx Group (MDXG) in Q4 2018, closing a stake of 674,268 shares — an estimated $4.17M sold.

Cloverdale Capital Management first reported a position in MDXG in Q3 2018 and held it in 1 quarter. The position peaked at $4.17M in Q3 2018. 38 funds tracked by Wall St. Rank hold MDXG as of Q4 2018.

Cloverdale Capital Management reported no remaining MiMedx Group position as of Q4 2018 after selling out during the quarter.
Cloverdale Capital Management sold 674,268 MiMedx Group shares in Q4 2018, an estimated $4.17M.
Cloverdale Capital Management first reported a position in MiMedx Group in Q3 2018 and held it in 1 quarter.
Cloverdale Capital Management's MiMedx Group position peaked at $4.17M in Q3 2018.
38 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2018.

Based on Cloverdale Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.